Journal of Pharma and Drug Innovation

Frequency : Quarterly
Editorial & Review Timeline
3 - 9 Days Initial Quality Review
14 Days Peer Evaluation Summary
80% Final Acceptance Rate After Peer Review
35 - 45 Days Complete Editorial Processing Time

Ismael Valladolid Acebes

Ph.D

  • Affiliation: Group Leader - Signal Transduction Unit
  • Department: Department of Molecular Medicine and Surgery
  • University: Karolinska Institute
  • Email: ismael.valladolid.acebes@ki.se
  • Country: Sweden

Dr. Ismael Valladolid-Acebes is Group Leader and Director of the Signal Transduction Unit at the Rolf Luft Research Center for Diabetes and Endocrinology, Department of Molecular Medicine and Surgery, Karolinska Institutet and Karolinska University Hospital in Stockholm. He holds a Licentiate in Pharmacy, an MPhil in Pharmacology, a PhD in Medical Science, and an MS in Clinical Research from Spanish universities. His research focuses on molecular and cellular mechanisms regulating metabolic and endocrine homeostasis, especially pancreatic islet biology, insulin secretion, metabolic stress pathways, and diabetes and its complications. He has published more than 40 scientific articles and is actively involved in teaching, supervision, and international academic service.

  • Group Leader and Director, Signal Transduction Unit

  • Teaching in metabolic and endocrine disorders

  • Supervisor of PhD and postdoctoral researchers

  • Invited lecturer in Spain, Italy, Slovenia, and Sweden

  • Reviewer for international journals

  • Member of thesis and examination committees

  • Evaluator for national and international research agencies

  • More than 40 scientific publications

  • Articles in journals such as:

    • Nature Communications

    • Science Advances

    • Diabetologia

    • Signal Transduction and Targeted Therapy

    • Biomedicines